A COX-2 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

FK-3311

Item No. 17697

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
N-[4-acetyl-2-(2,4-difluorophenoxy)phenyl]-methanesulfonamide
CAS Number
116686-15-8
Synonyms
  • COX-2 Inhibitor V
Molecular Formula
C15H13F2NO4S
Formula Weight
341.3
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 30 mg/mlDMSO: 30 mg/mlEthanol: 5 mg/ml
λmax
225, 272 nm
SMILES
FC1=CC(F)=CC=C1OC2=C(NS(C)(=O)=O)C=CC(C(C)=O)=C2
InChi Code
InChI=1S/C15H13F2NO4S/c1-9(19)10-3-5-13(18-23(2,20)21)15(7-10)22-14-6-4-11(16)8-12(14)17/h3-8,18H,1-2H3
InChi Key
DIIYLGZNZGPXRR-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    500 µg

    $49

    Add

    1 mg

    $86

    Add

    5 mg

    $167

    Add

    10 mg

    $236

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    FK3311 is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID).1,2 FK3311 inhibits LPS-induced thromboxane B2 (TxB2; Item No. 19030) production (IC50 = 316 nM) in vitro and inhibits adjuvant-induced arthritis (ED50 = 0.29 mg/kg) in rats without causing gastrointestinal irritation. FK3311 also alleviates ischemia-repurfusion injury in canine liver and rat lung in vivo.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Tsuji, K., Nakamura, K., Konishi, N., et al. Synthesis and pharmacological properties of 2'-phenoxy-methanesulfonanilide derivatives. Chem. Pharm. Bull. (Tokyo) 40(9), 2399-2409 (1992).

    2. Grossman, C.J., Wiseman, J., Lucas, F.S., et al. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm. Res. 44(6), 253-257 (1995).

    3. Sunose, Y., Takeyoshi, I., Ohwada, S., et al. The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. J. Am. Coll. Surg. 192(1), 54-62 (2001).

    4. Otani, Y., Takeyoshi, I., Yoshinari, D., et al. Effects of the COX-2 inhibitor FK3311 on ischemia - reperfusion injury in the rat lung. J. Invest. Surg. 20(3), 175-180 (2007).